RU93034195A - METHOD FOR DIAGNOSTIC OF SEPTIC STATES - Google Patents

METHOD FOR DIAGNOSTIC OF SEPTIC STATES

Info

Publication number
RU93034195A
RU93034195A RU93034195/14A RU93034195A RU93034195A RU 93034195 A RU93034195 A RU 93034195A RU 93034195/14 A RU93034195/14 A RU 93034195/14A RU 93034195 A RU93034195 A RU 93034195A RU 93034195 A RU93034195 A RU 93034195A
Authority
RU
Russia
Prior art keywords
septic
diagnostic
supernatant
diagnosis
septic states
Prior art date
Application number
RU93034195/14A
Other languages
Russian (ru)
Other versions
RU2117295C1 (en
Inventor
М.Я. Малахова
С.В. Оболенский
Original Assignee
М.Я. Малахова
С.В. Оболенский
Filing date
Publication date
Application filed by М.Я. Малахова, С.В. Оболенский filed Critical М.Я. Малахова
Priority to RU93034195A priority Critical patent/RU2117295C1/en
Priority claimed from RU93034195A external-priority patent/RU2117295C1/en
Publication of RU93034195A publication Critical patent/RU93034195A/en
Application granted granted Critical
Publication of RU2117295C1 publication Critical patent/RU2117295C1/en

Links

Claims (1)

Разработан способ диагностики септических состояний путем исследования супернатанта, который получается из биологических жидкостей путем осаждения крупномолекулярных белков. Цель изобретения - повышение чувствительности и надежности способа и ускорение диагностики. Супернатант исследуют в слабокислой среде в зоне ультрафиолета в диапазоне длин волн 238-300 нм и в случае выявления эффекта зазубренности на спектрограмме судят о наличии септического состояния.A method has been developed for the diagnosis of septic conditions by examining the supernatant, which is obtained from biological fluids by precipitation of large molecular proteins. The purpose of the invention is to increase the sensitivity and reliability of the method and accelerate the diagnosis. The supernatant is examined in a weakly acidic environment in the ultraviolet region in the wavelength range of 238-300 nm and, in the event of a serration effect being detected on the spectrogram, the presence of a septic state is judged.
RU93034195A 1993-07-01 1993-07-01 Method of diagnosis of septic states RU2117295C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93034195A RU2117295C1 (en) 1993-07-01 1993-07-01 Method of diagnosis of septic states

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93034195A RU2117295C1 (en) 1993-07-01 1993-07-01 Method of diagnosis of septic states

Publications (2)

Publication Number Publication Date
RU93034195A true RU93034195A (en) 1996-11-10
RU2117295C1 RU2117295C1 (en) 1998-08-10

Family

ID=20144353

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93034195A RU2117295C1 (en) 1993-07-01 1993-07-01 Method of diagnosis of septic states

Country Status (1)

Country Link
RU (1) RU2117295C1 (en)

Similar Documents

Publication Publication Date Title
DE59705683D1 (en) IMMUNOLOGICAL DETECTION METHOD OF ANTIBODIES TARGETED AGAINST TISSUE TRANSGLUTAMINASE (tTG), USE OF tTG FOR DIAGNOSIS AND THERAPY CONTROL, AND ORAL PHARMACEUTICAL AGENT CONTAINING tTG
ATE222254T1 (en) USE OF A METALLOPORPHYRIN CONJUGATE FOR DETECTING BIOLOGICAL COMPOUNDS
DE69937368D1 (en) PROBATION OF KIDNEY DISEASES AND TREATMENT
KR930022086A (en) Diagnostic Analysis of Alzheimer's Disease Based on Proteolysis of Amyloid Precursor Protein
ATE132909T1 (en) METHOD FOR DIAGNOSING BLOOD CLOTTING DISORDERS
ES2192611T3 (en) PROCEDURE FOR THE ELIMINATION OF THE INTERFERENCE OF THE REUMATOID FACTOR IN THE DOSAGES OF DIAGNOSIS.
EP1612280A3 (en) Diagnosis and treatment of Williams syndrome
WO2004091361A3 (en) Optical capsule and spectroscopic method for treating or diagnosing the intestinal tract
ATE347697T1 (en) METHOD FOR DETERMINING PROTEIN FRAGMENTS IN BODY FLUID
PT931264E (en) DIAGNOSTIC METHOD OF ATEROSCLEROSIS
WO2001016184A3 (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
RU93034195A (en) METHOD FOR DIAGNOSTIC OF SEPTIC STATES
EP0346119A3 (en) Anti-fc assay for detection of antibodies
EP1059087A1 (en) Antigens from rheumatoid autoimmune diseases
CA2213083A1 (en) Detection of antibody production
DE68928106D1 (en) DETECTION, QUANTIFICATION AND CLASSIFICATION OF RAS PROTEINS IN BODY LIQUIDS AND TISSUES
ATE192236T1 (en) HUMAN PHOSPHOLIPASE ACTIVATE PROTEIN PART
WO1999001085A3 (en) Autoimmune inner ear disease antigen and diagnostic assay
Takashi et al. Significant elevation of urinary 28-kD calbindin-D and N-acetyl-β-D-glucosaminidase levels in patients undergoing extracorporeal shock wave lithotripsy
WO2003054547A3 (en) Diagnosis of dementia utilizing thrombospondin
WO2002053016A3 (en) Compounds and methods for the diagnosis and treatment of babesia infection
SU1663546A1 (en) Method for diagnostication of increased sensitivity of auditory system to otopathogenic effects
RU95100387A (en) Method for detecting diatomic algae in blood of drowned men
DE69026868D1 (en) DNA sample for the detection of human parainfluenza type 2 virus
ATE119291T1 (en) METHOD FOR DETERMINING ANTIBODIES AGAINST CAUSES OF INFECTIOUS DISEASES IN BODY FLUID, MEANS THEREOF AND THEIR USE IN THIS METHOD.